Advocacy intelligence hub — real-time data for patient organizations
Tang-Du Hospital — NA
Xuanwu Hospital, Beijing
Tianjin Medical University General Hospital — PHASE2
Uplizna is indicated for for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients who are anti-aquaporin-4 (AQP4) antibody positive.
Beijing Tiantan Hospital
University of Texas Southwestern Medical Center
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Foundation grants
Foundation Grants1
HealthWell Foundation — Neuromyelitis optica spectrum disorder
HealthWell Foundation
Patient Assistance Programs1
SOLIRIS
Alexion Pharmaceuticals Inc.
Uplizna
(INEBILIZUMAB)Orphan drugHorizon Therapeutics USA, Inc.
CD19-directed Cytolytic Antibody [EPC]
12.1 Mechanism of Action The mechanism by which inebilizumab-cdon exerts its therapeutic effects in NMOSD, IgG4-RD, and gMG is presumed to involve bin...
Enspryng
(SATRALIZUMAB)Orphan drugstandardGenentech, Inc.
12.1 Mechanism of Action The precise mechanism by which satralizumab-mwge exerts therapeutic effects in NMOSD is unknown but is presumed to involve in...
Ultomiris
(RAVULIZUMAB)Orphan drugstandardAlexion Pharmaceuticals Inc.
Jinliang Chen, PhD
Second Affiliated Hospital, School of Medicine, Zhejiang University
Xiangjun Chen
Huashan Hospital
Jing Zhang
Huashan Hospital
Darin T. Okuda, MD, M.D
University of Texas Southwestern Medical Center
📍 DALLAS, TX
Wei Wang, MD
Tongji Hospital
Michael Levy, MD, PhD
Johns Hopkins University
📍 Boston, Massachusetts
View all Neuromyelitis optica spectrum disorder specialists →